CNS THERAPEUTICS XCHANGE
EAST COAST 2023
Boston
May 24, 2023

Welcome to hubXchange’s CNS Therapeutics Xchange East Coast 2023, bringing together executives from pharma and biotech to address and find solutions to the key issues faced in developing CNS therapies.

Discussion topics will cover Novel Targets, Preclinical, Clinical Studies and Drug Delivery.

Take advantage of this unique highly interactive meeting format designed for maximum engagement, collaboration and networking with your peers.

Please note this is an In-Person meeting. 

VENUE DETAILS: Hilton Boston Woburn Hotel, 2 Forbes Road, Woburn MA 01801

SNAPSHOTS OF DISCUSSION TOPICS

  • Novel therapies for complex neurological disorders: discovery of effective treatments
  • Opportunities from emerging therapeutic modalities: Target selection in an evolving druggability landscape
  • Methods to increase the success rates of drugs entering clinical phases
  • Novel strategies for reverse translation of temporal biomarkers for CNS drug development
  • Relevant in vitro mechanistic profiling to guide SAR and downstream in vivo studies
  • Utilizing clinical biomarkers to enhance drug development in neurodegenerative diseases
  • Are circulating neurodegeneration biomarkers ready for prime time?
  • Fluid and digital biomarkers in neurodegenerative disorders
  • Transcytosis-mediated brain delivery for proteins, antibodies, oligonucleotides, and small molecules
  • Non-invasive methods to increase brain drug uptake

Full Xchange Agenda

Click on each track for detailed agenda

Novel Targets

Time
Titles and Bullets
Facilitator
08:00 – 08:30
Registration

08:30 – 09:00

Opening Address & Keynote Presentation

09:05 – 10:05

Novel therapies for complex neurological disorders: discovery of effective treatments

Vice President – Global Medical Affairs, Praxis Precision Medicines

10:10 – 10:40
1-2-1 Meetings/Networking Break
10:40 – 11:10
1-2-1 Meetings / Networking Break
11:10 – 11:20
Morning Refreshments
11:10 – 11:20
Morning Refreshments
11:20 – 12:20

Sponsor-led Roundtable

12:20 – 13:20

Networking Lunch

13:20 – 13:50

Spotlight Presentation

13:55 – 14:25

1-2-1 Meetings / Networking Break

14:25 – 14:55

1-2-1 Meetings / Networking Break

15:35 – 16:35

Opportunities from emerging therapeutic modalities: Target selection in an evolving druggability landscape

R&D Director of Advanced Analytical Sciences, Noveome Biotherapeutics, Inc.

16:35 – 16:45
Afternoon Refreshments
17:45 – 18:45
Evening Drinks Reception

Partners

CNS Therapeutics Xchange | East Coast 2023
Register